Marching to the tune of the groundswell generated by Western Covid-19 vaccines approved, distributed and administered in the US, UK and the EU in recent weeks, Chinese...
Baxter BioPharma Solutions has contracted to support production of US biotech Novavax’s new Covid-19 vaccine in Germany, when it is approved. Phase 3 data from late...
Germany’s BioNTech has scaled up its projections for the number of doses of its Covid-19 vaccine it will make this year from 1.3 billion to 2 billion, as it seeks...
French pharma Sanofi is once again boosting its immunotherapy capabilities, this time with the acquisition of UK biotech Kymab. The company will make an upfront payment...
The UK’s Medicines and Healthcare Products Regulatory Agency (MRHA) cleared US biotech Moderna’s mRNA-based Covid-19 vaccine for emergency use on Jan. 7, bringing the...
As it rolls out an increasing number of doses of its mRNA-based Covid-19 vaccine, US biotech Moderna has appointed a pharma industry veteran to spearhead the effort...
CureVac has agreed a collaboration with Bayer to speed up production and distribution of its Covid-19 vaccine candidate CVnCOV, which began clinical trials in December...
Moderna’s mRNA-based Covid-19 vaccine will become the second to be administered in Europe. The European Commission granted a conditional marketing authorization to the...
Novozymes is to buy US-based Microbiome Labs, strengthening the Danish biotech’s presence in probiotics and gaining entry into the important North American market. The...
Unsurprisingly in view of the surging cases of Covid-19 worldwide, there was little interruption in the flow of vaccine news – or at least talk about vaccines– during...
